相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A non-affinity purification process for GMP production of prefusion-closed HIV-1 envelope trimers from clades A and C for clinical evaluation
Krishana Gulla et al.
VACCINE (2021)
Fusion peptide priming reduces immune responses to HIV-1 envelope trimer base
Angela R. Corrigan et al.
CELL REPORTS (2021)
Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen
Li Ou et al.
SCIENTIFIC REPORTS (2020)
Mapping Polyclonal Antibody Responses in Non-human Primates Vaccinated with HIV Env Trimer Subunit Vaccines
Bartek Nogal et al.
CELL REPORTS (2020)
Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses
Gwo-Yu Chuang et al.
JOURNAL OF VIROLOGY (2020)
Four Decades of HIV/AIDS - Much Accomplished, Much to Do
Anthony S. Fauci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell Signature
Cheng Cheng et al.
CELL REPORTS (2020)
Antibody-guided structure-based vaccines
Peter D. Kwong et al.
SEMINARS IN IMMUNOLOGY (2020)
Overcoming Challenges in Structural Characterization of HIV-1 Envelope Glycoprotein by LC-MS/MS
Vera B. Ivleva et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2019)
A proof of concept for structure-based vaccine design targeting RSV in humans
Michelle C. Crank et al.
SCIENCE (2019)
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure
Peter D. Kwong et al.
IMMUNITY (2018)
Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1
Kai Xu et al.
NATURE MEDICINE (2018)
Site-Specific Glycosylation of Virion-Derived HIV-1 Env Is Mimicked by a Soluble Trimeric Immunogen
Weston B. Struwe et al.
CELL REPORTS (2018)
Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity
Gwo-Yu Chuang et al.
JOURNAL OF VIROLOGY (2017)
Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation
Tongqing Zhou et al.
CELL REPORTS (2017)
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody
Rui Kong et al.
SCIENCE (2016)
Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env
Young Do Kwon et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Antibody potency relates to the ability to recognize the closed, pre-fusion form of HIV Env
Miklos Guttman et al.
NATURE COMMUNICATIONS (2015)
Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env
Young Do Kwon et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Structure and immune recognition of trimeric pre-fusion HIV-1 Env
Marie Pancera et al.
NATURE (2014)
Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions
James B. Munro et al.
SCIENCE (2014)
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
Rogier W. Sanders et al.
PLOS PATHOGENS (2013)
The Antibody Response against HIV-1
Julie Overbaugh et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Vaccine-Induced HIV Seropositivity/Reactivity in Noninfected HIV Vaccine Recipients
Cristine J. Cooper et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Magnitude and Breadth of a Nonprotective Neutralizing Antibody Response in an Efficacy Trial of a Candidate HIV-1 gp120 Vaccine
Peter Gilbert et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand
Punnee Pitisuttithum et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates
DH Barouch et al.
JOURNAL OF VIROLOGY (2005)
Antigenic conservation and immunogenicity of the HIV coreceptor binding site
JM Decker et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial
PB Gilbert et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure
JM Binley et al.
JOURNAL OF VIROLOGY (2000)
分享论文
